Clinical trial

Level of HER2-neu Gene Amplification an Response to Trastuzumab

NCT00874146

StatusUNKNOWN
Study typeOBSERVATIONAL
Start date2009-03-01
PhaseN/A

Study timeline

Study start (unknown)2009-03-01Date precision: month
Registry last updated2010-09-02
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.